2011 Annual Meeting of the American Society of Clinical Oncology^®

Top News from the 2011 Annual Meeting of the American Society of Clinical Oncology ^®
Among the 2011 Annual Meeting of the American Society of Clinical Oncology ^® highlights: 2 new drugs may change the face of melanoma treatment and 2 new strategies may change practice in breast cancer.

ASCO ^® 2011 Wrap-up: Getting the GIST of It
Four leading oncologists discuss the future of medical oncology, both at home and around the world, as we advance our understanding of how the genome can influence cancer treatment.

Clinical Trials: What Needs to Change?
Kathy D. Miller, MD; Maurie Markman, MD; David J. Kerr, MD; Robert L. Comis, MD

It Takes a Village to Cure Cancer
David J. Kerr, MD

• Global Cancer Epidemic -- A 'Crisis in Slow Motion'
  Medscape Medical News, June 20, 2011
• Bankruptcy Rates High Among Cancer Patients
  Medscape Medical News, June 16, 2011
• Faster Response Rates in CML with Bosutinib
  Medscape Medical News, June 15, 2011
• New Agent for Lymph Node Mapping in Breast Cancer, Melanoma
  Medscape Medical News, June 10, 2011
• 'Compelling' Activity With Targeted Therapies for Melanoma
  Medscape Medical News, June 10, 2011
• Long-Term Doxorubicin Linked to Secondary Oral Cancers
  Medscape Medical News, June 10, 2011
• Keep It Going? Pemetrexed Continuation Improves PFS in NSCLC
  Medscape Medical News, June 8, 2011
• First Drug for Myelofibrosis Offers Symptom Relief
  Medscape Medical News, June 7, 2011
• Abiraterone in Prostate Cancer, Survival Gets Even Better
  Medscape Medical News, June 6, 2011
• Oncologists, PCPs Need to Improve Care of Cancer Survivors
  Medscape Medical News, June 6, 2011
• Can New Standard of Care in Neuroblastoma Be Used in the US?
  Medscape Medical News, June 6, 2011
• First-Line Ipilimumab Also Improves Overall Survival
  Medscape Medical News, June 6, 2011
• 'Time to Celebrate'; New Metastatic Melanoma Agent Wows ASCO
  Medscape Medical News, June 6, 2011
• Long-Term Imatinib Extends Survival in High-Risk GIST
  Medscape Medical News, June 6, 2011
• Mutation-Specific Therapy in Lung Cancer: This is the Future
  Medscape Medical News, June 6, 2011
• Bevacizumab Benefits Patients With Recurrent Ovarian Cancer
  Medscape Medical News, June 5, 2011
• 'Surprising' Result in Flaxseed-for-Hot-Flashes Study
  Medscape Medical News, June 5, 2011
• First-Line Bevacizumab Improves Survival in Ovarian Cancer
  Medscape Medical News, June 5, 2011
• Exemestane -- A New Option for Breast Cancer Prevention
  Medscape Medical News, June 4, 2011
• Practice-Changing Radiation Study in Early Breast Cancer?
  Medscape Medical News, June 4, 2011
• Personalized Therapy Trials Up Response and Survival
  Medscape Medical News, June 3, 2011
• High-Dose Methotrexate Improves Survival in High-Risk ALL
  Medscape Medical News, June 3, 2011
• What's Happening at ASCO This Year
  Medscape Medical News, June 2, 2011
• Some Patients Don't Take Oral Anticancers Due to Cost
  Medscape Medical News, May 26, 2011
• Impact of Smoking on Breast Cancer Risk Greater Than Thought
  Medscape Medical News, May 24, 2011
• Dual Pathway Inhibitor Shows Broad Activity in Multiple Tumor Types
  Medscape Medical News, May 23, 2011
• PARP Inhibitor Improves Outcomes in Ovarian Cancer
  Medscape Medical News, May 20, 2011
• Genetic Biomarkers May Predict Taxane-Induced Neuropathy
  Medscape Medical News, May 19, 2011
• Cervical Cancer Screening Every 3 Years for Most Women
  Medscape Medical News, May 19, 2011